Mechanical Aspiration in ST Elevation ACS

In ST elevation ACS the preferred treatment is primary PCI. However, one its limitations is thrombus presence and its distal embolization, which threatens microcirculation perfusion and is therefore associated to ventricular function deterioration and bad evolution.

Aspiración mecánica en el IAM con supradesnivel del ST

Manual thrombus aspiration has been tested in different studies but the problem remains unsolved; mechanical thrombectomy might be a solution to this complication, so difficult to handle. 

The CHEETAH study (prospective, multicenter) included 400 patients with ST-ACS presenting within 12 hrs. of symptom onset treated with mechanical thrombectomy with CAT RX Aspiration System (Penumbra Inc, Alameda CA). 

Primary end point was a composite of cardiovascular death, repeat MI, cardiogenic shock or new class IV cardiac failure at 30 days.

Mean age was 60, most patients were men, 25% were diabetic, 2% had prior CABG and 20% prior PCI.

Most patients were in Killip class I-II. Compromised arteries were the right coronary, in half of patients, followed by the anterior descending and, less frequently, the circumflex. 

Read also: ACC 2023 | Subanalysis of the REVIVED-BICS Study2.

 Final rates of TIMI 0 was 99.50%, TIMI flow 3, 97.50% and myocardial blush grade 3 was 99.75%, with no device complications. 

Primary end point occurred in 3.6% of cases (95% CI, 2.0–6.0%) compared against the historical rate of 6.1%  (Pnoninferiority <0.001).

At 30 days, cardiovascular mortality was 0.51%, stroke 0.77%, major bleeding 1%.

Conclusion

Mechanical aspiration before PCI in acute coronary syndrome with high thrombus burden was safe, and was associated to high thrombus removal with flow restauration and normal perfusion on final angiography. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board ofSOLACI.org.

Original Title: Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study.

Reference: S. Jay Mathews, et al. Circ Cardiovasc Interv. 2023;16:e012433. DOI: 10.1161/CIRCINTERVENTIONS.122.012433. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...